Is this aligned with current FDA cybersecurity expectations?

Yes. Mobile Application Penetration Testing is delivered against the FDA's 2026 premarket cybersecurity guidance, ANSI/AAMI SW96, ISO 14971, IEC 62304, and IEC 81001-5-1 - and structured to land cleanly in eSTAR.

How is the engagement priced and how long does it take?

Fixed-fee, scoped after a free 30-minute Discovery Session. Most premarket engagements (penetration testing, threat modeling, SBOM, deficiency response) complete in 4-8 weeks. We typically start within 1-2 weeks of contract signature.

What if the FDA still pushes back after we submit?

We back our work with a no failed-clearance guarantee. If your submission is delayed because of a cybersecurity deficiency in our deliverables, we resolve it at no additional cost until your device is cleared.

Application Security

Mobile Application Penetration Testing

OWASP MASVS-aligned mobile testing - local data storage, network communication, platform interaction, and binary protections.

250+ FDA submissions. Zero rejections.

Senior team
Fixed-fee
Reviewer-ready
Re-test included

Book Strategy Session

Free 30-min call
No obligation
Senior expert, not a sales rep
Fixed-fee quote in 24 hours
NDA available on request

Trusted by leading MedTech companies

Reviewed by Christian Espinosa, MBA, CISSP · Founder & CEO

Last reviewed

Attack surface

Mobile companion app surface

A medical-device companion app is rarely just a UI. It carries pairing material, holds patient data at rest, brokers BLE traffic, and talks to a cloud API that often has more privilege than the device itself.

01App binary (iOS / Android)
02Local storage (Keychain / Keystore, SQLite, files)
03BLE / Wi-Fi broker layer
04Pairing + bonding material handling
05Cloud API client + auth tokens
06Push / background-task channels
07Third-party SDKs (analytics, crash, ML)
08OS interop (clipboard, share, screen capture)

Layers shown outermost (top) to innermost (bottom). Dashed rows are part of the surrounding system but out of scope for this view.

What's included

Reviewer-ready deliverables in one engagement

Every mobile application penetration testing engagement ships with the artifacts FDA reviewers expect to see - traceable, complete, and aligned with current guidance.

Local data storage analysis
Network and API communication
Platform and IPC interaction
Binary hardening and reverse engineering

Relevant standards

Standards this service maps to

Every mobile application penetration testing engagement produces evidence aligned to the regulatory and consensus standards FDA reviewers and notified bodies expect to see - traceable, complete, and ready to drop into your ISO 13485 quality system.

Featured site-wide

OWASP MASVS

Mobile Application Security Verification Standard

Verification requirements for iOS / Android companion app security controls.

FDA 2026 Guidance Featured

FDA Premarket Cybersecurity Guidance (Feb 3, 2026)

Defines the SPDF, Section 524B submission package, threat modeling, SBOM, security architecture views, and cybersecurity testing every cyber device submission must include.

ANSI/AAMI SW96 Featured

Medical Device Security Risk Management

The consensus standard for medical device security risk management - asset, threat, vulnerability, likelihood, severity, and residual risk acceptability.

NIST SP 800-115

Technical Guide to Information Security Testing

Reference methodology for planning, executing, and reporting security testing.

Notable incidents

Public premarket cybersecurity history

Recalls, CISA ICS-MA advisories, and disclosed research that shape what reviewers ask about - and what this engagement is built to cover.

OWASP·Ongoing

OWASP MASVS / MSTG as reviewer baseline

OWASP MASVS is the de facto baseline reviewers compare mobile evidence against. A pen test that cannot point at MASVS coverage is now flagged.

Advisory

MedTech segments